In 2019, compound 1–2 (vinyl sulfonamide, Figure 4) was demonstrated to activate Nrf2 and then the antioxidant enzymes were enhanced and finally MPTP-induced PD mouse model was ameliorated (Choi et al., 2019b). This evidence concerns the gene NFE2L2 and Parkinson disease.